公式動画ピックアップ

AAPL   ADBE   ADSK   AIG   AMGN   AMZN   BABA   BAC   BL   BOX   C   CHGG   CLDR   COKE   COUP   CRM   CROX   DDOG   DELL   DIS   DOCU   DOMO   ESTC   F   FIVN   GILD   GRUB   GS   GSK   H   HD   HON   HPE   HSBC   IBM   INST   INTC   INTU   IRBT   JCOM   JNJ   JPM   LLY   LMT   M   MA   MCD   MDB   MGM   MMM   MSFT   MSI   NCR   NEM   NEWR   NFLX   NKE   NOW   NTNX   NVDA   NYT   OKTA   ORCL   PD   PG   PLAN   PS   RHT   RNG   SAP   SBUX   SHOP   SMAR   SPLK   SQ   TDOC   TEAM   TSLA   TWOU   TWTR   TXN   UA   UAL   UL   UTX   V   VEEV   VZ   WDAY   WFC   WK   WMT   WORK   YELP   ZEN   ZM   ZS   ZUO  

  公式動画&関連する動画 [Dilution Cloning by Real-Time Cell Analysis with xCELLigence RTCA eSight]

Single cell clonal screening an important step in monoclonal antibody production cell line optimization, stable cell line construction, gene editing, and drug target screening. With the xCELLigence RTCA eSight Dilution Cloning assays, you can now use whole well imaging (5x objective) to quickly identify colonies and verify monoclonality. With automated imaging and software, easily pinpoint clones derived from a single cell and track colony formation in real-time. Using either label or label-free methods, researchers can easily measure colony growth and monitor growth characteristics of clones (i.e. rapidly dividing). Instead of relying on labor intensive and manual-based methods that can be subject to error, the eSight allows for rapid identification of wells that contain clones of interest– all inside your incubator. Using plate view of colonies over time (i.e. Day 0 to Day 10) eSight enables and provides simple and accurate screening of monoclonal cell lines with insightful data. The tracking and monitoring of monoclonal formation is made fully possible using the Dilution Cloning eSight software module, and brightfield and fluorescent focusing. Confluency and object count metrics allow you to quantify emerging colonies, while having the flexibility to stop, rewind, or move forward based on points of interest. Learn More: https://bit.ly/46j6tfX
 99      0